title: Development and implementation of a comprehensive, criteria-based drug-use review program.
abstract: A comprehensive drug-use review (DUR) program based on established criteria for use of each drug is described. The DUR program was developed to promote cost-effective drug therapy and satisfy Joint Commission on Accreditation of Hospitals standards for drug-use evaluation. Antibiotic and ambulatory-care drug-use subcommittees composed of physicians, pharmacists, nurses, and clinical laboratory personnel were formed as advisory groups to the pharmacy and therapeutics (P&T) committee. The subcommittees review overall drug-use patterns in their respective areas monthly and investigate the use of specific problem drugs. Drug-use reviews have been facilitated by the implementation of a mandatory antibiotic order form and pharmacy computer systems. Nonformulary drug use is monitored. The procedure for adding drugs to the formulary was modified to require the submission of specific criteria for appropriate drug use; when a drug is added to the formulary, the criteria for use are also adopted. The program has been successful in curtailing inappropriate drug use, reducing drug expenditures, and integrating P&T committee decisions into daily pharmacy practice. The implementation of this DUR program has enabled the P&T committee to conduct ongoing, systematic, criteria-based drug-use evaluations.
authors.forename: M W
authors.initials: MW
authors.lastname: Todd
authors.forename: T D
authors.initials: TD
authors.lastname: Keith
authors.forename: M T
authors.initials: MT
authors.lastname: Foster
mesh_terms: D000553:Ambulatory Care; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004363:Drug Utilization / Q000592:standards*; D005431:Florida; D005572:Formularies, Hospital as Topic; D006745:Hospital Bed Capacity, 300 to 499; D007591:Joint Commission on Accreditation of Healthcare Organizations; D008962:Models, Theoretical; D010607:Pharmacy Service, Hospital / Q000458:organization & administration*; D010606:Pharmacy and Therapeutics Committee / Q000458:organization & administration*
chemical_list: D000900:Anti-Bacterial Agents